PRF1 and glioma: γδ T cells are a rare subset of T cells with the potential to exert anti-tumor functions in an MHC-independent manner through IFNγ, perforin, and granzyme B release [62], with anti-glioma activity demonstrated in vitro and in vivo [63, 64].